医学
随机对照试验
2型糖尿病
糖尿病
减肥
内科学
肥胖
物理疗法
内分泌学
作者
Shi Zhang,Yi Wang,Xincheng Wang,Mingxin Leng,Renjiao Liu,Zhouhuiling Li,Jing Li,Jing Xiao,Dangmin Hou,Xinying Gao,Chunjun Li
出处
期刊:BMC Medicine
[BioMed Central]
日期:2025-05-07
卷期号:23 (1)
标识
DOI:10.1186/s12916-025-04072-4
摘要
This study aimed to explore the effects of hypoglycemic agents with weight loss effect plus a high protein diet and moderate exercise on weight loss and diabetes remission in adults with obesity and newly diagnosed prediabetes/type 2 diabetes (T2D). Participants with obesity and newly diagnosed prediabetes or T2D (n = 61) were randomly allocated to standard treatment group (conventional medication and lifestyle guidance for 12 months) and intensive treatment group (in addition to conventional medication, a high protein diet and moderate exercise were given for 12 months). By month 12, 60 (98.4%) participants completed the 12-month follow-up visit. In the intensive treatment group, 73.33% patients in the prediabetes subgroup returned to normoglycemia and the diabetes remission rate was 86.67% in the diabetes subgroup, which were much higher than the remission rate of prediabetes subgroup (7.69%) and diabetes subgroup (16.67%) in the standard treatment group (P < 0.001). The mean weight change was - 19.29 kg (95% CI, - 22.95 to - 15.63) in the intensive treatment group and - 1.52 kg (95% CI, - 5.12 to 2.07) in the standard treatment group from baseline after intervention. The weight change between the two groups was significantly different (net difference, - 17.77 kg; 95% CI, - 22.90 to - 12.64; P < 0.001). Percent of body fat, visceral fat area, and hepatic controlled attenuation parameter value reduced significantly in the intensive treatment group compared to the standard treatment group (P < 0.001). Hypoglycemic agents with weight loss effect plus a high protein diet and moderate exercise could lead to a considerable proportion of patients with diabetes achieving diabetes remission. chictr.org.cn ChiCTR2100044305.
科研通智能强力驱动
Strongly Powered by AbleSci AI